- Trials with a EudraCT protocol (755)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
755 result(s) found for: Diagnosis Related Groups.
Displaying page 1 of 38.
EudraCT Number: 2012-002763-10 | Sponsor Protocol Number: VB-201-079 | Start Date*: 2012-10-11 | |||||||||||
Sponsor Name:Vascular Biogenics Ltd. | |||||||||||||
Full Title: A Randomized, Double-Blind, Dose-Ranging, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral VB-201 in Patients with Moderate to Severe Plaque Psoriasis | |||||||||||||
Medical condition: Patients with Moderate to Severe Plaque Psoriasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005271-12 | Sponsor Protocol Number: MetForMe | Start Date*: 2021-05-03 |
Sponsor Name:Erasmus MC, Department of Dermatology | ||
Full Title: Rediscovery of metformin for the chronic disabling auto-inflammatory disease hidradenitis suppurativa | ||
Medical condition: Hidradenitis suppurativa | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-002061-38 | Sponsor Protocol Number: S53299 | Start Date*: 2011-06-29 | ||||||||||||||||
Sponsor Name:Katholieke Universiteit Leuven | ||||||||||||||||||
Full Title: A randomised prospective trough level monitoring study with real-time therapeutic adaptations: Trough level Adapted infliXImab Treatment scheme (TAXIT). | ||||||||||||||||||
Medical condition: 2) Crohn's disease and ulcerative colitis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-001013-41 | Sponsor Protocol Number: CIGE025A2210 | Start Date*: 2008-01-18 |
Sponsor Name:Novartis Pharma Services AG | ||
Full Title: A randomized, double-blind, placebo-controlled study to demonstrate the efficacy of Xolair in an allergen bronchoprovocation study in two asthmatic populations defined by serum IgE concentrations | ||
Medical condition: Asthma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-002311-41 | Sponsor Protocol Number: 2014-3 | Start Date*: 2014-08-12 |
Sponsor Name:GETAID | ||
Full Title: A proSpective randomized controlled trial comParing infliximAb-antimetabolites combination therapy to anti-metabolites monotheRapy and infliximab monothErapy in Crohn’s disease patients in sustaine... | ||
Medical condition: Luminal Crohn’s disease patients with steroid free remission for at least 6 months and a combination therapy with infliximab and anti-metabolites for at least 1 year | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FR (Ongoing) GB (GB - no longer in EU/EEA) SE (Ongoing) DE (Ongoing) NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-003876-39 | Sponsor Protocol Number: P04371 | Start Date*: 2006-09-19 | |||||||||||
Sponsor Name:Integrated Therapeutics Group, Incorporated-a subsidiary of Schering Plough | |||||||||||||
Full Title: A Randomized, Open-label, Multi-center, Phase 3, 2-arm Study Evaluating the Efficacy and Safety of Peg interferon Alfa-2b Low-dose Maintenance Monotherapy Versus Standard Supportive Care in Patient... | |||||||||||||
Medical condition: Cirrhotic Hepatitis C Co-infected With Human Immunodeficiency Virus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003212-39 | Sponsor Protocol Number: LPM-008 | Start Date*: 2019-12-17 | |||||||||||
Sponsor Name:Lightpoint Medical Ltd | |||||||||||||
Full Title: Evaluation of the LightPath Imaging System and the PET tracer 68Ga-RM2 in wide local excision (WLE) for breast cancer | |||||||||||||
Medical condition: Wide local excision (WLE) for breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002682-30 | Sponsor Protocol Number: RALATOR | Start Date*: 2015-09-30 | ||||||||||||||||
Sponsor Name:Fundació Lluita contra la SIDA | ||||||||||||||||||
Full Title: Raltegravir-based regimen versus raltegravir-based regimen plus atorvastatin for reducing ?inflamaging? (aging-related complication) in HIV-infected patients older than 60 years. | ||||||||||||||||||
Medical condition: aging-related inflamation in HIV-infected patients | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-005216-15 | Sponsor Protocol Number: ABO-NB-15 | Start Date*: 2016-07-06 | |||||||||||||||||||||
Sponsor Name:ABOCA S.P.A. SOCIETà AGRICOLA | |||||||||||||||||||||||
Full Title: Relief of heartburn and epigastric pain comparing Neobianacid® with omeprazole: a randomized, double blind, double dummy, reference product controlled, parallel group, non-inferiority clinical study | |||||||||||||||||||||||
Medical condition: GERD (Gastroesophageal Reflux Disease) and/or EPS (Epigastric Pain Syndrome) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002620-18 | Sponsor Protocol Number: IM101-046 | Start Date*: 2005-05-13 |
Sponsor Name:Bristol-Myers Squibb International Corporation | ||
Full Title: A Multi-National Randomized, Double-Blind, Exploratory Study of Abatacept versus Placebo in Preventing the Development of Rheumatoid Arthritis in Adult Subjects with Undifferentiated Inflammatory A... | ||
Medical condition: Rheumatoid Arthritis, NOS | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) GB (Completed) BE (Completed) IT (Completed) ES (Completed) | ||
Trial results: Removed from public view |
EudraCT Number: 2013-004418-17 | Sponsor Protocol Number: I-BCT-1 | Start Date*: 2014-05-07 |
Sponsor Name:Oslo University Hospital | ||
Full Title: Improved breast cancer therapy (I-BCT-1) in the neoadjuvant and metastatic setting: A phase 2 clinical trial protocol studying biological rationale for the optimal selection of treatment regimens. | ||
Medical condition: breast cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-003497-48 | Sponsor Protocol Number: EMPATHY | Start Date*: 2021-11-29 | |||||||||||
Sponsor Name:Medical University of Warsaw | |||||||||||||
Full Title: Empagliflozin and dapagliflozin in patients hospitalized for acute decompensated heart failure (EMPATHY) – a phase III trial | |||||||||||||
Medical condition: acute decompensated heart failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021015-16 | Sponsor Protocol Number: TFM-CL3-002 | Start Date*: 2010-09-30 | |||||||||||
Sponsor Name:Olympus France SAS | |||||||||||||
Full Title: A Phase III, Double-Blind, Placebo Controlled, Parallel Group, International, Multicenter Study of 12 Weeks Treatment with Trafermin 0.01% Spray in Patients with Diabetic Foot Ulcer of Neuropathic ... | |||||||||||||
Medical condition: Wound closure rate of diabetic foot ulcers (DFUs) of neuropathic origin. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) BE (Completed) DK (Completed) SE (Completed) DE (Completed) NL (Completed) HU (Completed) SK (Completed) BG (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001778-17 | Sponsor Protocol Number: 201190 | Start Date*: 2016-03-17 | |||||||||||
Sponsor Name:GlaxoSmithKline Biologicals | |||||||||||||
Full Title: A phase IIIb, open-label, multi-country, multi-centre, long-term follow-up study (ZOE-LTFU) of studies 110390 and 113077 (ZOSTER-006/022) to assess the prophylactic efficacy, safety, and immunogeni... | |||||||||||||
Medical condition: Vaccination against HZ and its related complications in adults older than 50 years (at the time of primary vaccination). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) EE (Completed) CZ (Completed) GB (GB - no longer in EU/EEA) DE (Completed) ES (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002990-24 | Sponsor Protocol Number: RAD1901-308 | Start Date*: 2019-05-29 | |||||||||||
Sponsor Name:Stemline Therapeutics, Inc. | |||||||||||||
Full Title: Elacestrant Monotherapy vs. Standard of Care for the Treatment of Patients with ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, Open-Label, Active-Control... | |||||||||||||
Medical condition: Advanced breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Ongoing) FR (Ongoing) HU (Completed) AT (Ongoing) GR (Ongoing) IE (Ongoing) PT (Ongoing) DK (Completed) ES (Ongoing) GB (GB - no longer in EU/EEA) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000729-13 | Sponsor Protocol Number: 2020_0068 | Start Date*: 2021-01-21 |
Sponsor Name:Hôpital Foch | ||
Full Title: Evaluation of Glucocorticoids plus Rituximab compared to Glucocorticoids plus Placebo for the treatment of patients with newly-diagnosed or relapsing IgA vasculitis : A prospective, randomized, con... | ||
Medical condition: Patients with a diagnosis of IgAV according to Chapel Hill Consensus Conference definitions. Patients will require having a biopsy-proven diagnosis of IgAV. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-005101-31 | Sponsor Protocol Number: AV001 | Start Date*: 2014-06-17 | |||||||||||
Sponsor Name:Pfizer Inc | |||||||||||||
Full Title: A Multicenter Phase 3 Randomized, Open-Label Study of Bosutinib versus Imatinib in Adult Patients with Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia | |||||||||||||
Medical condition: Chronic Myeloid Leukemia (CML) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) IT (Completed) SE (Completed) CZ (Completed) HU (Completed) SK (Completed) FI (Completed) NO (Completed) ES (Completed) DK (Completed) NL (Completed) PL (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000757-22 | Sponsor Protocol Number: 114700 | Start Date*: 2011-06-28 | |||||||||||
Sponsor Name:GlaxoSmithKline Biologicals | |||||||||||||
Full Title: A Phase IIIb open-label, randomised, multi-centre primary immunization study to evaluate the immunogenicity and safety of GSK Biologicals’ HPV-16/18 L1 VLP AS04 vaccine when administered intramuscu... | |||||||||||||
Medical condition: Cervarix is indicated in females from 10 years of age onwards for the prevention of persistent infection, premalignant cervical lesions and cervical cancer (squamous-cell carcinoma and adenocarcino... | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002466-11 | Sponsor Protocol Number: version125/05/05 | Start Date*: 2006-01-03 |
Sponsor Name:King's College Hospital | ||
Full Title: A Pilot Study to Examine the Safety and Efficacy of Posterior Juxtascleral Triamcinolone acetonide administration, in addition to Visudyne photoynamic therapy for predominantly Classic Choroidal N... | ||
Medical condition: Classic or predominantly classic age related macular degeneration | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2021-000094-91 | Sponsor Protocol Number: RC31/20/0518 | Start Date*: Information not available in EudraCT |
Sponsor Name:Toulouse University Hospital | ||
Full Title: EFFECT OF INTRANASAL OXYTOCIN ON DYSPHAGIA RELATED TO OROPHARYNGO-OESOPHAGEAL DYSMOTILITY TRANSIT IN CHILDREN AND ADOLESCENTS WITH PRADER-WILLI SYNDROME: A PHASE 3 STUDY (DYSMOT) | ||
Medical condition: Prader-Willi Syndrome | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.